Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Single-Dose Vials per carton (NDC 39822-1030-2); Rx only, Distributed by: X-Gen Pharmaceuticals, Inc., Big Flats, NY 14814; Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645.
Published April 12, 2017 · Recall initiated: February 8, 2017
Summary
FDA records drug Class I recall D-0637-2017, published April 12, 2017 and initiated February 8, 2017. Recalling firm: X-Gen Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 2593 cartons; Lot: PLND1613, Exp 02/18. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email if IBUPROFEN LYSINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IBUPROFEN LYSINE
- Manufacturer
- X-Gen Pharmaceuticals Inc.
- Distributor
- Nationwide in the USA.
- Lot
- PLND1613, Exp 02/18
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACiclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDCApril 12, 2017
- FDAVancomycin Hydrochloride for Injection, USP, 10 grams, Pharmacy Bulk Package - Not For Direct Infusion, ForApril 12, 2017
- FDAAdalat CC (nifedipine) Extended-Release Tablets, 90 mg, 100-count bottles, Rx Only, Manufactured for AlmaticaApril 12, 2017
- FDAVancomycin HCl 1.25 g added to 5% Dextrose 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals, LittleApril 12, 2017
- FDAAdalat CC (nifedipine) Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for AlmaticaApril 12, 2017
- FDAVancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals,April 12, 2017
Questions about this recall
Was Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Single-Dose Vials per carton (NDC 39822-1030-2); Rx only, Distributed by: X-Gen Pharmaceuticals, Inc., Big Flats, NY 14814; Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. recalled?
Yes. FDA published recall D-0637-2017 on April 12, 2017. Reported hazard: Presence of Particulate Matter
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IBUPROFEN LYSINE.